Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000239038

Medchemexpress LLC KRCA-0008 | 1472795-20-2 | MFCD28133395 | 96.2% | 609.12 g/mol | C30H37ClN8O4 | 50MG
SDP

Supplier:  Medchemexpress LLC HY1233150MG

Encompass_Preferred

KRCA-0008 is a potent, selective dual inhibitor of anaplastic lymphoma kinase (ALK) and activated Cdc42-associated kinase 1 (Ack1/TNK2), intended for research use in oncology and kinase signaling studies. It exhibits low-nanomolar biochemical potency and has shown in vivo activity in tumor models.

  • Potent dual ALK and Ack1 inhibition (ALK IC50 = 12 nM; Ack1 IC50 = 4 nM).
  • Suitable for cancer biology and kinase signaling research.
  • Reported molecular formula C30H37ClN8O4 and molecular weight 609.12 g/mol.
  • Available in multiple laboratory pack sizes in milligram quantities.
  • Purity reported by suppliers varies; consult the certificate of analysis for the supplied batch.
  • Research use only; not for human or veterinary application.

Catalog No. 50-002-39038


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.